Health Care [ 2/12 ] | Pharmaceuticals [ 27/74 ]
NASDAQ | Common Stock
Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders.
The company' preclinical product includes HLP005, a phenethylamine and tryptamine derivative to treat central nervous system.
It has a strategic partnership agreement with Segal Trials to evaluating HLP003 for the adjunctive treatment of major depressive disorder; and with Osmind for mental health treatments.
The company is headquartered in Toronto, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 11, 26 | -0.93 Increased by +3.65% | -0.80 Decreased by -16.82% |
| Jun 28, 26 | -1.02 Increased by +30.14% | -1.04 Increased by +1.92% |
| Feb 12, 26 | -1.36 Decreased by -156.60% | -0.98 Decreased by -38.78% |
| Nov 12, 25 | -1.65 Increased by +42.31% | -1.33 Decreased by -24.06% |
| Jun 30, 25 | -0.97 Decreased by -27.63% | -1.10 Increased by +11.98% |
| Jun 29, 25 | -1.46 Decreased by -84.48% | -1.23 Decreased by -18.70% |
| Feb 9, 25 | -0.53 Increased by +84.50% | -1.57 Increased by +66.24% |
| Nov 12, 24 | -2.86 Decreased by -50.53% | -0.91 Decreased by -214.29% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 30, 26 | 1.30 M Increased by +N/A% | -46.99 M Decreased by -53.68% | Decreased by -3.62 K% Decreased by N/A% |
| Dec 30, 25 | 0.00 Decreased by N/A% | -42.63 M Decreased by -293.23% | Decreased by N/A% Decreased by N/A% |
| Sep 29, 25 | 0.00 Decreased by N/A% | -47.03 M Increased by +17.34% | Decreased by N/A% Decreased by N/A% |
| Jun 29, 25 | 0.00 Decreased by N/A% | -24.61 M Decreased by -127.13% | Decreased by N/A% - |
| Mar 30, 25 | 0.00 Decreased by N/A% | -30.58 M Decreased by -43.25% | Decreased by N/A% - |
| Dec 30, 24 | 0.00 Decreased by N/A% | -10.84 M Increased by +64.25% | Decreased by N/A% - |
| Sep 29, 24 | 0.00 Decreased by N/A% | -56.90 M Decreased by -378.55% | Decreased by N/A% - |
| Jun 29, 24 | N/A Decreased by N/A% | -10.83 M Increased by +25.35% | - - |